SudaMediCa, The Sudanese Medical Community

Subcutaneous methotrexate can be given at higher doses than in the oral route and still maintain its bioavailability, which could make it easier for patients to tolerate the drug and for clinicians to better adhere to treatment guidelines, a pharmacokinetic study suggested. In other recent rheumatol...